{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:07:39Z","timestamp":1776982059780,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6853","license":[{"start":{"date-parts":[[2001,9,20]],"date-time":"2001-09-20T00:00:00Z","timestamp":1000944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,9,20]],"date-time":"2001-09-20T00:00:00Z","timestamp":1000944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2001,9,20]]},"DOI":"10.1038\/35095083","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:32:48Z","timestamp":1027657968000},"page":"323-327","source":"Crossref","is-referenced-by-count":209,"title":["A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase"],"prefix":"10.1038","volume":"413","author":[{"given":"Nisar P.","family":"Malek","sequence":"first","affiliation":[]},{"given":"Holly","family":"Sundberg","sequence":"additional","affiliation":[]},{"given":"Seth","family":"McGrew","sequence":"additional","affiliation":[]},{"given":"Keiko","family":"Nakayama","sequence":"additional","affiliation":[]},{"given":"Themis R.","family":"Kyriakidis","sequence":"additional","affiliation":[]},{"given":"James M.","family":"Roberts","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF35095083_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149\u20131163 (1995).","journal-title":"Genes Dev."},{"key":"BF35095083_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","volume":"85","author":"ML Fero","year":"1996","unstructured":"Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733\u2013744 (1996).","journal-title":"Cell"},{"key":"BF35095083_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0960-9822(99)80086-4","volume":"9","author":"S Coats","year":"1999","unstructured":"Coats, S. et al. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr. Biol. 9, 163\u2013173 (1999).","journal-title":"Curr. Biol."},{"key":"BF35095083_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nm0598-575","volume":"4","author":"V Ophascharoensuk","year":"1998","unstructured":"Ophascharoensuk, V., Fero, M. L., Hughes, J., Roberts, J. M. & Shankland, S. J. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nature Med. 4, 575\u2013580 (1998).","journal-title":"Nature Med."},{"key":"BF35095083_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/24179","volume":"396","author":"ML Fero","year":"1998","unstructured":"Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M. & Kemp, C. J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177\u2013180 (1998).","journal-title":"Nature"},{"key":"BF35095083_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter, P. L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222\u2013225 (1997).","journal-title":"Nature Med."},{"key":"BF35095083_CR7","first-page":"1259","volume":"57","author":"P Tan","year":"1997","unstructured":"Tan, P. et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res. 57, 1259\u20131263 (1997).","journal-title":"Cancer Res."},{"key":"BF35095083_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm0297-227","volume":"3","author":"C Catzavelos","year":"1997","unstructured":"Catzavelos, C. et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Med. 3, 227\u2013230 (1997).","journal-title":"Nature Med."},{"key":"BF35095083_CR9","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1128\/MCB.16.8.4327","volume":"16","author":"D Agrawal","year":"1996","unstructured":"Agrawal, D. et al. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB\/c 3T3 cells. Mol. Cell. Biol. 16, 4327\u20134336 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"BF35095083_CR10","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","volume":"271","author":"L Hengst","year":"1996","unstructured":"Hengst, L. & Reed, S. I. Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861\u20131864 (1996).","journal-title":"Science"},{"key":"BF35095083_CR11","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1128\/MCB.20.16.5947-5959.2000","volume":"20","author":"SS Millard","year":"2000","unstructured":"Millard, S. S., Vidal, A., Markus, M. & Koff, A. A U-rich element in the 5\u2032 untranslated region is necessary for the translation of p27 mRNA. Mol. Cell. Biol. 20, 5947\u20135959 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BF35095083_CR12","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1101\/gad.11.11.1464","volume":"11","author":"RJ Sheaff","year":"1997","unstructured":"Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M. & Clurman, B. E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464\u20131478 (1997).","journal-title":"Genes Dev."},{"key":"BF35095083_CR13","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1002\/j.1460-2075.1996.tb01050.x","volume":"15","author":"J Vlach","year":"1996","unstructured":"Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D. & Amati, B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15, 6595\u20136604 (1996).","journal-title":"EMBO J."},{"key":"BF35095083_CR14","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1038\/sj.onc.1201440","volume":"15","author":"D Muller","year":"1997","unstructured":"Muller, D. et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E\/cdk2 complexes. Oncogene 15, 2561\u20132576 (1997).","journal-title":"Oncogene"},{"key":"BF35095083_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.7624798","volume":"269","author":"M Pagano","year":"1995","unstructured":"Pagano, M. et al. Role of the ubiquitin\u2013proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682\u2013685 (1995).","journal-title":"Science"},{"key":"BF35095083_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0092-8674(00)80404-3","volume":"91","author":"RM Feldman","year":"1997","unstructured":"Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p\/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221\u2013230 (1997).","journal-title":"Cell"},{"key":"BF35095083_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)80098-7","volume":"86","author":"C Bai","year":"1996","unstructured":"Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263\u2013274 (1996).","journal-title":"Cell"},{"key":"BF35095083_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(00)80403-1","volume":"91","author":"D Skowyra","year":"1997","unstructured":"Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209\u2013219 (1997).","journal-title":"Cell"},{"key":"BF35095083_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/12027","volume":"1","author":"H Sutterluty","year":"1999","unstructured":"Sutterluty, H. et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol. 1, 207\u2013214 (1999).","journal-title":"Nature Cell Biol."},{"key":"BF35095083_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s001090050081","volume":"75","author":"M Rolfe","year":"1997","unstructured":"Rolfe, M., Chiu, M. I. & Pagano, M. The ubiquitin-mediated proteolytic pathway as a therapeutic area. J. Mol. Med. 75, 5\u201317 (1997).","journal-title":"J. Mol. Med."},{"key":"BF35095083_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol. 1, 193\u2013199 (1999).","journal-title":"Nature Cell Biol."},{"key":"BF35095083_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0960-9822(99)80290-5","volume":"9","author":"LM Tsvetkov","year":"1999","unstructured":"Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H. & Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661\u2013664 (1999).","journal-title":"Curr. Biol."},{"key":"BF35095083_CR23","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/emboj\/19.9.2069","volume":"19","author":"K Nakayama","year":"2000","unstructured":"Nakayama, K. et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19, 2069\u20132081 (2000).","journal-title":"EMBO J."},{"key":"BF35095083_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/387422a0","volume":"387","author":"G Leone","year":"1997","unstructured":"Leone, G., DeGregori, J., Sears, R., Jakoi, L. & Nevins, J. R. Myc and Ras collaborate in inducing accumulation of active cyclin E\/Cdk2 and E2F. Nature 387, 422\u2013426 (1997).","journal-title":"Nature"},{"key":"BF35095083_CR25","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1101\/gad.827200","volume":"14","author":"RC O'Hagan","year":"2000","unstructured":"O'Hagan, R. C. et al. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 14, 2185\u20132191 (2000).","journal-title":"Genes Dev."},{"key":"BF35095083_CR26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501\u20131512 (1999).","journal-title":"Genes Dev."},{"key":"BF35095083_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1994.059.01.003","volume":"59","author":"M Hatakeyama","year":"1994","unstructured":"Hatakeyama, M. et al. The cancer cell and the cell cycle clock. Cold Spring Harb. Symp. Quant. Biol. 59, 1\u201310 (1994).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BF35095083_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1073\/pnas.71.4.1286","volume":"71","author":"AB Pardee","year":"1974","unstructured":"Pardee, A. B. A restriction point for control of normal animal cell proliferation. Proc. Natl Acad. Sci. USA 71, 1286\u20131290 (1974).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35095083_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0960-9822(98)70254-4","volume":"8","author":"A Nagy","year":"1998","unstructured":"Nagy, A. et al. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8, 661\u2013664 (1998).","journal-title":"Curr. Biol."},{"key":"BF35095083_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1046\/j.1523-1747.1999.00755.x","volume":"113","author":"TR Kyriakides","year":"1999","unstructured":"Kyriakides, T. R., Tam, J. W. & Bornstein, P. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J. Invest. Dermatol. 113, 782\u2013787 (1999).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/35095083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/35095083","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/35095083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T23:19:56Z","timestamp":1640301596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35095083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,20]]},"references-count":30,"journal-issue":{"issue":"6853","published-print":{"date-parts":[[2001,9,20]]}},"alternative-id":["BF35095083"],"URL":"https:\/\/doi.org\/10.1038\/35095083","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1000972.9760","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,20]]}}}